| |
|
|
|
Acasti Pharma  
|
|
1.01 -0.07 (-0.06%) |
04-20 16:00 |
|
Open: |
1.06 |
Pre close: |
1.08 |
Target:
|
1.29 
|
|
High: |
1.0732 |
Low: |
1 |
Resistance:
|
1.11
1.19
|
|
Volume: |
188,043 |
Market Cap: |
26M |
Support:
|
0.97
0.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.07
|
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
1.08 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
1.13 |
Stochastic Oscillator |
%K(14,3):
|
35.09 |
|
MA(250): |
1.25 |
%D(3): |
48.06 |
|
Average Volume(K) |
3-Month: |
20875
|
52-Week |
High:
|
3.36 |
|
10-Days: |
13539 |
Low: |
0.84 |
|
RSI |
RSI(14):
|
39.82 |
Change(%): |
-19.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-95.6 |
Shares Out. (M) |
25.64 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-68.3 |
Shares Float (M) |
25.64 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.20 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
270 |
|
Book Value (p.s.) |
2.390 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.42 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.02 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-5.16 |
|
|
|
|
|
|
